The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products, such as Ozempic, on the local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback